Opera Exceeds Q1 Expectations, Raises Full-Year Guidance, and Repurchases $17M in Shares
OPRA sits 48% above its 52-week low of $11.71.
Summary
Opera Ltd reported strong first-quarter results, surpassing revenue and adjusted EBITDA guidance, and subsequently raised its full-year outlook. The company also actively executed its share repurchase program, buying back $17.0 million in shares during the quarter.
Key Events · Earnings and Guidance · OPRA
-
Strong Q1 Performance
Opera reported first-quarter revenue of $175.8 million and adjusted EBITDA of $42.0 million, both exceeding the high end of the company's guidance ranges.
-
Raised Full-Year Guidance
The company raised its full-year 2026 revenue guidance to $727 - $740 million and adjusted EBITDA guidance to $170 - $174 million, reflecting increased confidence in its outlook.
-
Active Share Repurchase
Opera repurchased 1.14 million shares for a total of $17.0 million in March, at an average price of $14.88 per share, as part of its previously announced $300 million program.
-
Significant Cash Generation
Net cash flow from operating activities surged 164% year-over-year to $42.1 million, with free cash flow from operations increasing 195% to $35.5 million.
Analysis · OPRA · Technology
Opera's strong first-quarter performance, with both revenue and adjusted EBITDA surpassing the high end of guidance, signals robust operational execution. The subsequent increase in full-year guidance demonstrates management's heightened confidence in sustained growth and profitability. Furthermore, the active execution of the share repurchase program, with $17.0 million in shares bought back during the quarter, indicates a commitment to returning capital to shareholders and potentially suggests management views the stock as undervalued. This combination of strong results, optimistic outlook, and shareholder-friendly actions is a significant positive for investors.
At the time of this filing, OPRA was trading at $17.29 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.71 to $21.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.